RemeGen
RemeGen is a biopharmaceutical company with operations in China and the United States. The company develops and commercializes biological drugs for autoimmune, oncology, and ophthalmology diseases.
1
Funding Rounds
$100.0m
Money raised
Overview
RemeGen is a biopharmaceutical company with operations in China and the United States. The company develops and commercializes biological drugs for autoimmune, oncology, and ophthalmology diseases.
- Website:
- Headquarters: Yantai
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company RemeGen has raised a total of $100m in funding over 1 rounds.
Key Insights:
- RemeGen Funding round, April 2020: $100m
RemeGen Funding round, April 2020
$100m
Industries
RemeGen is active in the following industries: